• Atopic Dermatitis
    • Ulrich Wahn
    • Ulrich Wahn: Influence Statistics

      Ulrich Wahn

      Ulrich Wahn

      Show email address

      Division of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, Germany. | Guy's and St Thomas' Hospital, London Bridge Hospital, London, ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Ulrich Wahn:Expert Impact

      Concepts for whichUlrich Wahnhas direct influence:Atopic dermatitis,Allergic rhinitis,Cystic fibrosis,Specific ige,Spina bifida,Grass pollen,Sublingual immunotherapy,Food allergy.

      Ulrich Wahn:KOL impact

      Concepts related to the work of other authors for whichfor which Ulrich Wahn has influence:Atopic dermatitis,Allergic rhinitis,Food allergy,Cystic fibrosis,Sublingual immunotherapy,Childhood asthma,Specific ige.

      KOL Resume for Ulrich Wahn


      Division of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, Germany.

      Guy's and St Thomas' Hospital, London Bridge Hospital, London, United Kingdom.

      Department of Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany


      Klinik für Pädiatrie m.S. Pneumologie und Immunologie, Charite-Berlin, Berlin, Germany


      Charité Medical University, Berlin, Germany.

      Charite, Berlin, Germany


      Department of Paediatric Pneumology, Immunology and Intensive Care Unit, Charité Universitätsmedizin Berlin, Berlin, Germany


      Department of Pediatrics, Division of Pneumology, Immunology Charité - Universitätsmedizin Berlin, Berlin, Germany;


      Pediatric Pneumology and Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany


      e Department of Paediatric Pulmonology and Immunology, Charité Virchow-Klinikum , Humboldt University , Berlin , Germany.


      Department of Paediatric Pneumology and Immunology, Charité Virchow-Klinikum, Humboldt University, Berlin, Germany


      Department of Pediatric Pneumology and Immunology, Charité–Universitätsmedizin Berlin, Berlin, Germany

      Klinik für Pädiatrie mit Schwerpunkt Pneumologie und Immunologie, Charité–Universitätsmedizin Berlin


      Department of Pediatric Allergology and Immunology, Charité University Medical Center, Berlin, Germany

      Berlin, Berlin, Deutschland


      Department of Pediatric Pneumology and Immunology, Charité–Universitätsmedizin Berlin, Berlin

      Mitglied des wissenschaftlichen Beirates des Netzwerks „Gesund ins Leben - Netzwerk Junge Familie“


      Berlin Children's Hospital, Charité/Campus Virchow‐Klinikum, Berlin, Germany

      Sign-in to see all concepts, it's free!
      Sample of concepts for which Ulrich Wahn is among the top experts in the world.
      Concept World rank
      study infantsfed ehf #1
      fcs children #1
      severity rescue #1
      mild asthma montelukast #1
      ige grass pollen #1
      asthma 10year followup #1
      pollen peak efficacy #1
      clinicians allergen immunotherapy #1
      operations latex #1
      interferonγ assays germany #1
      il5 pha #1
      oral bacteria child #1
      blood‐ige #1
      54171 #1
      hydrolysed infant formulae #1
      schulproblemen #1
      skin symptoms worsening #1
      ppv sensitization #1
      urinary histamine‐ #1
      specificity clinical outcome #1
      common indoor age #1
      control populations association #1
      tige sige levels #1
      development subsequent asthma #1
      tuberculosis ntml #1
      higher risk sensitization #1
      scit tnsss #1
      age specific sensitization #1
      encasings specific immunotherapy #1
      ifngamma secretion slit #1
      late wheezers age #1
      allergens early #1
      asthma sensitised infants #1
      mycobacterium tuberculosis tuberculin #1
      atopic father #1
      immunoglobulin medical #1
      13 yrs #1
      pulse therapy gc #1
      initiation subcutaneous immunotherapy #1
      latex age #1
      role ecp concentration #1
      serum ecp concentration #1
      pollen risk factors #1
      grass pollen start #1
      birth cohort igg #1
      association atopic phenotypes #1
      responders immunologic #1
      sensitization inhalant #1
      disease humans hypersensitivity #1
      inhalant age #1
      Sign-in to see all concepts, it's free!

      Prominent publications by Ulrich Wahn

      KOL-Index: 23063

      OBJECTIVE: Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory cytokines, is effective in atopic dermatitis (AD). We assessed whether early treatment of AD signs/symptoms with pimecrolimus could influence long-term outcome by preventing disease flares.

      METHODS: Early intervention with pimecrolimus was compared with a conventional AD treatment strategy (ie, emollients and topical corticosteroids). In this 1-year, controlled, double-blind study, 713 AD patients (2-17 ...

      Known for Patients Pimecrolimus | 12 Months | Atopic Dermatitis | Incidence Adverse Events | Disease Flares
      KOL-Index: 18923

      BACKGROUND: Controversial data have emerged regarding the question whether cat exposure in childhood favours or decreases the risk of sensitization and allergic airway disease. In a prospective birth-cohort study, we assessed the association between longitudinal cat allergen exposure, sensitization (immunoglobulin E, IgE), IgG antibody (ab) levels to cat and the development of asthma in children up to the age of 10 years.

      METHODS: Of 1314 newborn infants enrolled in five German cities in ...

      Known for Specific Igg | Allergen Exposure | Asthma Children | Homes Cats | 10 Years
      KOL-Index: 18591

      BACKGROUND: Atopic dermatitis is commonly associated with food allergy. In addition to skin prick tests (SPTs) and measurements of specific IgE levels, the atopy patch test (APT) has recently been introduced into the diagnostic procedure for food allergy.

      OBJECTIVE: Our aim was to evaluate whether a combination of allergologic tests could improve the prognostic value of the individual tests for positive food challenge results. We hypothesized that the combination of a positive APT result ...

      Known for Specific Ige | Food Challenges | Atopic Dermatitis | Atopy Patch Test | Apt Ppv
      KOL-Index: 16660

      BACKGROUND: Specific IgE antibody responses to alimentary and environmental allergens are one of the hallmarks of atopic diseases. The knowledge of the time course of allergic sensitization during early life may facilitate measures for preventive interventions.

      OBJECTIVE: In a prospective birth cohort study (the Multicenter Allergy Study [MAS]) we investigated annual incidence and prevalence rates of sensitization to food and inhalant allergens during the first 6 years of life.

      METHODS: ...

      Known for 6 Years | Inhalant Allergens | Sensitization Food | 1 Year | Incidence Rates
      KOL-Index: 16590

      BACKGROUND: The treatment of allergic asthma by specific immunotherapy (SIT) is hampered by potential side-effects.

      OBJECTIVE: The aim of this study was to study the effect of omalizumab, a monoclonal anti-IgE antibody, in combination with SIT in patients with seasonal allergic rhinoconjunctivitis (SAR) and co-morbid seasonal allergic asthma (SAA) incompletely controlled by conventional pharmacotherapy.

      METHODS: A randomized, double-blind, placebo-controlled, multi-centre trial was ...

      Known for Allergic Asthma | Specific Immunotherapy | Monoclonal Antibodies | Omalizumab Treatment | Combination Patients
      KOL-Index: 15441

      BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.

      METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...

      Known for Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure
      KOL-Index: 15251

      BACKGROUND: While immediate-type clinical reactions to food can quite easily be identified by history or measurement of specific IgE in combination with positive oral food challenges, the evaluation of food allergy in the absence of immediate clinical reactions still presents diagnostic difficulties--particularly in children with atopic dermatitis. The objective of this study was to evaluate the diagnostic value of the atopy patch test (APT) with regard to late-phase reactions observed ...

      Known for Atopic Dermatitis | Food Allergy | Patch Test | Specific Ige | Positive Apt
      KOL-Index: 14626

      BACKGROUND: The skin of patients with atopic dermatitis exhibits a striking susceptibility to colonization and infection with Staphylococcus aureus. In this context it has been previously shown that S aureus-derived superantigens could function as classic allergens, inducing production of functionally relevant specific IgE antibodies.

      OBJECTIVE: The aim of this study was to determine the prevalence and the role of circulating staphylococcal enterotoxin A (SEA)- and staphylococcal ...

      Known for Atopic Dermatitis | Ige Antibodies | Seb Severity | Aureus Skin | Role Staphylococcal Enterotoxin
      KOL-Index: 14595

      There is a common progression known as the allergic march from atopic dermatitis to allergic asthma. Cetirizine has several antiallergic properties that suggest a potential effect on the development of airway inflammation and asthma in infants with atopic dermatitis.

      METHODS: Over a two year period, 817 infants aged one to two years who suffered from atopic dermatitis and with a history of atopic disease in a parent or sibling were included in the ETAC (Early Treatment of the Atopic ...

      Known for Asthma Cetirizine | Infants Atopic Dermatitis | Placebo‐controlled Trial | Grass Pollen | Airway Inflammation
      KOL-Index: 14578

      OBJECTIVES: Rotavirus is the leading cause of acute gastroenteritis requiring hospitalization in young children. Data on the burden of rotavirus gastroenteritis are needed to guide recommendations for rotavirus vaccine use. This study was undertaken to estimate the burden of rotavirus gastroenteritis in European children <5 years of age.

      METHODS: This prospective, study was conducted in 12 hospitals in France, Germany, Italy, Spain, and the United Kingdom. A sample of all children aged ...

      Known for 5 Years | Acute Gastroenteritis | Acquired Rotavirus | Children Aged | Study Burden
      KOL-Index: 14175

      The efficacy and safety of five-grass pollen 300IR sublingual immunotherapy (SLIT) tablets (Stallergènes SA, France) have previously been demonstrated in paediatric patients. This report presents additional data concerning efficacy at pollen peak, efficacy and safety according to age, nasal and ocular symptoms, use of rescue medication, satisfaction with treatment and compliance. Children (5-11 yr) and adolescents (12-17 yr) with grass pollen-allergic rhinoconjunctivitis were included in ...

      Known for Grass Pollen | Children Adolescents | Efficacy Safety | Slit Tablets | Preschool Desensitization
      KOL-Index: 13918

      Studies evaluating newer antihistamines in children are few. Levocetirizine is a potent and highly selective H1-antihistamine with a proven efficacy in adults. Primary objective was to assess the efficacy of levocetirizine 5 mg once-daily in reducing seasonal allergic rhinitis (SAR) symptoms, as measured by Total Four Symptom Score (T4SS = sum of sneezing, rhinorrhea, nasal and ocular pruritus), over the first 2 wk of treatment. Efficacy over 4 and 6 wk of treatment, effect on nasal ...

      Known for Children Levocetirizine | Nasal Congestion | Seasonal Allergic | Placebo Treatment | 6 Wk
      KOL-Index: 13873

      BACKGROUND: Specific immunotherapy (SIT) and treatment with monoclonal anti-IgE antibody have complementary modes of action.

      OBJECTIVE: The purpose of this study was to determine whether combined therapy could provide better efficacy than either treatment alone.

      METHODS: We conducted a randomized, double-blinded trial to assess the efficacy and safety of subcutaneously administered anti-IgE (omalizumab) or placebo in children and adolescents with seasonal allergic rhinitis in both a ...

      Known for Seasonal Allergic Rhinitis | Monoclonal Antibodies | Combination Treatment | Specific Immunotherapy | Grass Pollen
      KOL-Index: 13704

      BACKGROUND: Diagnosis of childhood tuberculosis (TB) is challenging. The widely used tuberculin skin test (TST) may produce -positive results because of cross-reactivity with nontuberculous mycobacteria or bacille Calmette-Guerin vaccination, resulting in unnecessary treatment. Two recently developed interferon- gamma release assays (IGRAs) show good diagnostic accuracy for active TB in adults; pediatric data are limited, particularly in areas with a low incidence of TB. We assessed the ...

      Known for Igras Children | Specificity Tst | Nontuberculous Mycobacteria | Release Assays | Diagnosis Tuberculosis

      Key People For Atopic Dermatitis

      Top KOLs in the world
      Donald Y M Leung
      atopic dermatitis eczema herpeticum food allergy
      Thomas RM Bieber
      atopic dermatitis dendritic cells lupus erythematosus
      Jon M Hanifin
      atopic dermatitis eczema herpeticum histamine release
      Mark Boguniewicz
      atopic dermatitis eczema herpeticum tacrolimus ointment
      Hywel C G Williams
      atopic eczema cochrane skin basal cell carcinoma
      Johnannes Ring
      atopic eczema west germany histamine release

      Division of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, Germany. | Guy's and St Thomas' Hospital, London Bridge Hospital, London, United Kingdom. | Department of Respiratory Medicine, Immunology and Critical Ca

    Download on the App StoreGet it on Google Play

    Copyright © 2023 KOL - Key Opinion Leaders, LLC.

    KOL does not provide medical advice, diagnosis or treatment.